First Photoactive Drug to fight Parkinson’s Disease
Source: University of Barcelona
Summary: An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson’s disease.
More Information: Jaume Taura et al, “Remote control of movement disorders using a photoactive adenosine A 2A receptor antagonist”, Journal of Controlled Release (2018). DOI: 10.1016/j.jconrel.2018.05.033